Medicinal Cannabis (MedCan 3) - randomised, multicentre, double blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer - UQ Researchers

Medicinal Cannabis (MedCan 3) - randomised, multicentre, double blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer (2021–2025)

Grant type:

NHMRC MRFF EPCDR Medicinal Cannabis

Researchers:

Honorary Professor Janet Hardy

Honorary Professor

Mater Research Institute-UQ

Faculty of Medicine
Associate Professor Rebecca Olson

Associate Professor

School of Social Science

Faculty of Humanities, Arts and Social Sciences
Dr Ristan Greer

Honorary Associate Professor

Mater Research Institute-UQ

Faculty of Medicine

Funded by:

Commonwealth Department of Health and Aged Care

The University of Queensland

Brisbane St Lucia, QLD 4072

+61 7 3365 1111

Other Campuses: UQ Gatton, UQ Herston

Maps and Directions

© 2024 The University of Queensland

A Member of

Privacy & Terms of use | Feedback

Authorised by: Director of OMC

ABN 63 942 912 684

CRICOS Provider No:00025B

Explore

Need Help?

Emergency

Ph. 3365 3333